Boardroom Alpha
Boardroom Alpha
BDL · Current Report (Form 8-K) · Filed March 6, 2025

Flanigans Enterprises Inc — Current Report (Form 8-K)

Form
8-K
Filed
March 6, 2025
Period
Feb 28, 2025
Ticker
BDL
Accession
0001174947-25-000296
Boardroom Alpha · Filing insights

Board nominees elected; executive compensation approved; advisory vote on pay to occur every three years.

About Flanigans Enterprises Inc
Market cap
$94M
1Y TSR
+47.5%
3Y TSR
+15.7%
Board grade
A
Sector
Consumer Cyclical
CEO
James Flanigan II
Last annual meeting: Feb 27, 2026 · View full Flanigans Enterprises Inc profile →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant To Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 28, 2025

 

FLANIGAN’S ENTERPRISES, INC.

(Exact name of registrant as specified in its charter)

 

Florida 1-6836 59-0877638
(State or other jurisdiction of (Commission (IRS Employer
of incorporation) File Number Identification Number)

 

5059 N.E. 18th Avenue, Fort Lauderdale, Florida 33334

(Address of principal executive office and ZIP code)

 

Registrant’s telephone number, including area code): (954) 377-1961

 

Check the appropriate box below if this Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 240.425)
Soliciting material pursuant to Rule14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading symbol(s) Name of each exchange on which registered
Common Stock, $0.10 par value BDL NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.07.Submission of Matters to a Vote of Security Holders.

 

(b) At the Annual Meeting of Shareholders, (the “Annual Meeting”) of Flanigan’s Enterprises, Inc., (the “Company”), held on February 28, 2025, of the 1,858,647 shares of Common Stock outstanding and entitled to vote, 1,062,878 shares were represented, constituting a 57.19% quorum. The final results for each of the matters submitted to a vote of shareholders at the Annual Meeting are as follows:

 

Proposal 1

 

All of the nominees of the Company’s Board of Directors (the “Board”) were elected to serve until the Company’s 2028 Annual Meeting or until their respective successors are elected and qualified, by the votes set forth in the table below:

 

Director For Withhold Authority Abstentions Broker Non-Votes
         
Jeffrey D. Kastner 892,695 170,183 -- --
Michael B. Flanigan 916,044 140,694 -- --
Mary E. Bennett 1,025,859 36,869 -- --

 

The terms of office of the following Directors continued after the meeting:

 

James G. Flanigan, August Bucci, Patrick J. Flanigan, Christopher O’Neil, Christopher J. Nelms and John P. Foster.

 

Proposal 2

 

The shareholders approved, on an advisory (non-binding) basis, the compensation of certain executive officers, by the votes set forth in the table below.

 

For Against Abstentions Broker Non-Votes
       
975,808 85,007 1,983 --

 

Proposal 3

 

The shareholders approved, on an advisory (non-binding) basis, the holding of an advisory (non-binding) vote on executive compensation every three years, by the votes set forth in the table below.

 

1 Year Frequency 2 Years Frequency 3 Years Frequency Abstentions Broker Non-Votes
         
118,563 508 939,627 -- --

 

Based on these results, and consistent with the Company’s recommendation, the Board has determined that the Company will hold an advisory vote on executive compensation every three years.

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  FLANIGAN’S ENTERPRISES, INC.
  (Registrant)
     
     
Date:  March 6, 2025 By:  /s/  Jeffrey D. Kastner
    Jeffrey D. Kastner
  Chief Financial Officer, General Counsel, Secretary
   

 

 

 

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Flanigans Enterprises Inc (BDL)

Reference

Frequently asked questions

When did Flanigans Enterprises Inc file this 8-K?
Flanigans Enterprises Inc (BDL) filed this Current Report (Form 8-K) with the SEC on March 6, 2025. The accession number assigned by EDGAR is 0001174947-25-000296.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Board nominees elected; executive compensation approved; advisory vote on pay to occur every three years. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Flanigans Enterprises Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Flanigans Enterprises Inc has filed under CIK 12040, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer